The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharamceutical compositions containing them and their use in therapy ##STR00001##
Claims What is claimed is: 1. A compound of formula (IA): ##STR00031## or a salt, ester or amide thereof; X is O or S, S(O) or S(O).sub.2, or NR.sup.6 where R.sup.6 is hydrogen or C.sub.1-6alkyl; R.sup.5a is a group of formula (a) or (b): ##STR00032## where * indicates the point of attachment to the group X in formula (I); R.sup.1', R.sup.2', R.sup.3', R.sup.4' are independently selected from hydrogen, halo, cyano, nitro, trifluoromethyl, C.sub.1-3alkyl, --NR.sup.7R.sup.8 or --X.sup.1R.sup.9; wherein at least one of R.sup.1', R.sup.2', R.sup.3' and R.sup.4' is --X.sup.1R.sup.9; R.sup.7 and R.sup.8 are independently hydrogen or C.sub.1-3alkyl; X.sup.1 is --O--, --CH.sub.2--, --OCO--, carbonyl, --S--, --SO--, --SO.sub.2--, --NR.sup.10CO--, --CONR.sup.11--, --SO.sub.2NR.sup.12--, --NR.sup.13SO.sub.2-- or --NR.sup.14--; R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are independently hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; R.sup.9 is selected from one of the following groups: 1) hydrogen or C.sub.1-5alkyl which may be unsubstituted or which may be substituted with one or more groups selected from hydroxy, fluoro or amino; 2) C.sub.1-5alkylX.sup.2COR.sup.15 wherein X.sup.2 represents --O-- or --NR.sup.16-- in which R.sup.15 represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.16 represents C.sub.1-3alkyl, --NR.sup.17R.sup.18 or --OR.sup.19 wherein R.sup.17, R.sup.18 and R.sup.19 which may be the same or different each represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 3) C.sub.1-5alkylX.sup.3R.sup.20 wherein X.sup.3 represents --O--, --S--, --SO--, --SO.sub.2--, --OCO--, --NR.sup.21CO--, --CONR.sup.22--, --SO.sub.2NR.sup.23--, --NR.sup.24SO.sub.2-- or --NR.sup.25-- wherein R.sup.21, R.sup.22, R.sup.23, R.sup.24 and R.sup.25 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.20 represents hydrogen, C.sub.1-3alkyl, cyclopentyl, cyclohexyl or a 5- or 6-membered saturated heterocyclic group with 1 or 2 heteroatoms, selected independently from O, S and N, which C.sub.1-3alkyl group may bear 1 or 2 substituents selected from oxo, hydroxy, halo and C.sub.1-4alkoxy and which cyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halo, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl and C.sub.1-4alkoxy; 4) C.sub.1-5alkylX.sup.4C.sub.1-5alkylX.sup.5R.sup.26 wherein X.sup.4 and X.sup.5 which may be the same or different are each --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.27CO--, --CONR.sup.28--, --SO.sub.2NR.sup.29--, --NR.sup.30SO.sub.2-- or --NR.sup.31-- wherein R.sup.27, R.sup.28, R.sup.29, R.sup.30 and R.sup.31 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.26 represents hydrogen or C.sub.1-3alkyl; 5) R.sup.32 wherein R.sup.32 is a 5- or 6-membered saturated heterocyclic group linked via carbon or nitrogen with 1 or 2 heteroatoms, selected independently from O, S and N, which heterocyclic group may bear 1 or 2 substituents selected from oxo, hydroxy, halo, C.sub.1-4alkyl, C.sub.1-4hydroxyalkyl, C.sub.1-4alkoxy, C.sub.1-4alkoxyC.sub.1-4alkyl and C.sub.1-4alkylsulphonylC.sub.1-4alkyl; 6) C.sub.1-5alkylR.sup.32 wherein R.sup.32 is as defined hereinbefore; 7) C.sub.2-5alkenylR.sup.32 wherein R.sup.32 is as defined hereinbefore; 8) C.sub.2-5alkynylR.sup.32 wherein R.sup.32 is as defined hereinbefore; 9) R.sup.33 wherein R.sup.33 represents a pyridone group, a phenyl group or a 5- or 6-membered aromatic heterocyclic group linked via carbon or nitrogen with 1, 2 or 3 heteroatoms selected from O, N and S, which pyridone, phenyl or aromatic heterocyclic group may carry up to 5 substituents on available carbon atoms selected from hydroxy, halo, amino, C.sub.1-4alkyl, C.sub.1-4alkoxy, C.sub.1-4hydroxyalkyl, C.sub.1-4aminoalkyl, C.sub.1-4alkylamino, C.sub.1-4hydroxyalkoxy, carboxy, trifluoromethyl, cyano, --CONR.sup.34R.sup.35 and --NR.sup.36COR.sup.37 wherein R.sup.34, R.sup.35, R.sup.36 and R.sup.37, which may be the same or different, each represents hydrogen, C.sub.1-4alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl; 10) C.sub.1-5alkylR.sup.33 wherein R.sup.33 is as defined hereinbefore; 11) C.sub.2-5alkenylR.sup.33 wherein R.sup.33 is as defined hereinbefore; 12) C.sub.2-5alkynylR.sup.33 wherein R.sup.33 is as defined hereinbefore; 13) C.sub.1-5alkylX.sup.6R.sup.33 wherein X.sup.6 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.38CO--, --CONR.sup.39--, --SO.sub.2NR.sup.40--, --NR.sup.41SO.sub.2-- or --NR.sup.42-- wherein R.sup.38, R.sup.39, R.sup.40, R.sup.41 and R.sup.42 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.33 is as defined hereinbefore; 14) C.sub.2-5alkenylX.sup.7R.sup.33 wherein X.sup.7 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.43CO--, --CONR.sup.44--, --SO.sub.2NR.sup.45--, --NR.sup.46SO.sub.2-- or --NR.sup.47-- wherein R.sup.43, R.sup.44, R.sup.45, R.sup.46 and R.sup.47 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.33 is as defined hereinbefore; 15) C.sub.2-5alkynylX.sup.8R.sup.33 wherein X.sup.8 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.48CO--, --CONR.sup.49--, --SO.sub.2NR.sup.50--, --NR.sup.51SO.sub.2-- or --NR.sup.52-- wherein R.sup.48, R.sup.49, R.sup.50, R.sup.51 and R.sup.52 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.33 is as defined hereinbefore; 16) C.sub.1-3alkylX.sup.9C.sub.1-3alkylR.sup.33 wherein X.sup.9 represents --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.53CO--, --CONR.sup.54--, --SO.sub.2NR.sup.55--, --NR.sup.56SO.sub.2-- or --NR.sup.57-- wherein R.sup.53, R.sup.54, R.sup.55, R.sup.56 and R.sup.57 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.33 is as defined hereinbefore; 17) C.sub.1-3alkylX.sup.9C.sub.1-3alkylR.sup.32 wherein X.sup.9 and R.sup.32 are as defined hereinbefore; 18) C.sub.1-5alkyl optionally substituted by 1, 2 or 3 halo; 19) C.sub.1-5alkylX.sup.10C.sub.1-5alkylX.sup.11R.sup.90 wherein X.sup.10 and X.sup.11, which may be the same or different, are each --O--, --S--, --SO--, --SO.sub.2--, --NR.sup.91CO--, --CONR.sup.92--, --SO.sub.2NR.sup.93--, --NR.sup.94SO.sub.2-- or --NR.sup.95-- where R.sup.91, R.sup.92, R.sup.93, R.sup.94 and R.sup.95 each independently represents C.sub.1-5alkyl, C.sub.1-3alkyl substituted by 1, 2 or 3 halo, C.sub.1-4alkyl or C.sub.1-4alkoxy groups and where there are 2 C.sub.1-4alkoxy groups the C.sub.1-4alkyl groups of alkoxy may together form a 5- or 6-membered saturated heterocyclic group having 2 oxygen atoms, C.sub.2-5alkenyl, C.sub.2-5alkynyl, C.sub.3-6cycloalkyl optionally substituted by halo, hydroxy, C.sub.1-3alkyl or C.sub.1-4hydroxyalkyl, C.sub.3-6cycloalkylC.sub.1-3alkyl optionally substituted by halo, hydroxy, C.sub.1-3alkyl or C.sub.1-4hydroxyalkyl or C.sub.1-3alkoxyC.sub.2-3alkyl and R.sup.90 represents hydrogen or C.sub.1-3alkyl; 20) C.sub.3-6cycloalkyl; 21) R.sup.96 wherein R.sup.96 is a 5- or 6-membered heterocyclic group which may be saturated or unsaturated linked via carbon or nitrogen with 1 or 2 heteroatoms, selected independently from O, S and N which heterocyclic group may bear 1 or 2 substituents selected from C.sub.1-4hydroxyalkyl, C.sub.1-4alkyl, hydroxy and C.sub.1-4alkoxyC.sub.1-4alkyl; 22) C.sub.1-5alkylR.sup.96 wherein R.sup.96 is defined hereinbefore; and where: R.sup.60 is hydrogen, nitro, halo, cyano, or C.sub.1-3alkyl; R.sup.61 is a group of sub-formula (k): ##STR00033## where: p is 0 or 1; q is 1; R.sub.1' and R.sub.1'' are independently hydrogen, hydroxy, halo, cyano, C.sub.1-10alkyl, C.sub.3-10cycloalkyl, C.sub.2-10alkenyl or C.sub.2-10alkynyl; wherein C.sub.1-10alkyl, C.sub.3-10cycloalkyl, C.sub.2-10alkenyl and C.sub.2-10alkynyl are optionally substituted by halo, nitro, cyano, hydroxy, trifluoromethyl, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C.sub.1-4alkyl, C.sub.2-4alkenyl, C.sub.2-4alkynyl, C.sub.3-6cycloalkyl, C.sub.3-6cycloalkenyl, C.sub.1-4alkoxy, C.sub.1-4alkanoyl, C.sub.1-4alkanoyloxy, C.sub.1-4alkanoylamino, N,N-di(C.sub.1-4alkanoyl)amino, N-(C.sub.1-4alkyl)carbamoyl, N,N-di(C.sub.1-4alkyl)carbamoyl, C.sub.1-4alkylS, C.sub.1-4alkylS(O), C.sub.1-4alkylS(O).sub.2, C.sub.1-4alkoxycarbonyl, N-(C.sub.1-4 alkyl)sulphamoyl, N,N-di(C.sub.1-4alkyl)sulphamoyl, C.sub.1-4alkylsulphonylamino or heterocyclyl; or R.sub.1' and R.sub.1'' can together form a 3- to 6-membered ring which may be saturated or unsaturated; T is C.dbd.O or SO.sub.n wherein n is 0, 1 or 2; V is independently selected from R.sup.63 or N(R.sup.63)R.sup.64; R.sup.63 is --(CH.sub.2).sub.q'R.sup.70 or aryl or heteroaryl where the latter two groups are optionally substituted by 1 or 2 substituents independently selected from halo, C.sub.1-4alkyl, C.sub.1-4alkoxy, trifluoromethyl, trifluoromethoxy, hydroxy, nitro, difluoromethyl, difluoromethoxy and cyano; R.sup.64 is hydrogen or C.sub.1-3alkyl; q' is 0 or 1 R.sup.70 is of formula (III): --K--J (III) K is a bond; J is aryl or heteroaryl which are both optionally substituted by 1, 2 or 3 substituents selected from halo, C.sub.1-3alkyl, C.sub.3-4cycloalkyl, C.sub.3-4cycloalkylC.sub.1-3alkyl, cyano and C.sub.1-3alkoxy; and R.sup.62 is hydrogen, halo or C.sub.1-3alkyl. 2. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sub.1' and R.sub.1'' are independently hydrogen or C.sub.1-3alkyl; T is C.dbd.O; and V is N(R.sup.63)R.sup.64. 3. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.63 is aryl optionally substituted by 1 or 2 substituents independently selected from halo, C.sub.1-4alkyl, C.sub.1-4alkoxy, trifluoromethyl, trifluoromethoxy, hydroxy, nitro, difluoromethyl, difluoromethoxy and cyano. 4. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sup.60 and R.sup.62 are both hydrogen, R.sup.61 is --CH.sub.2--CONR.sup.64-J and wherein J is phenyl optionally substituted by 1 or 2 halo. 5. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sup.9 is hydrogen, C.sub.3-6cycloalkyl, --C.sub.1-5alkyl-O--C.sub.1-3alkyl or a 5- to 6-membered saturated heterocyclic group linked via carbon or nitrogen with 1 or 2 heteroatoms selected independently from O, S or N which heterocyclic group is optionally substituted by C.sub.1-4alkyl or R.sup.9 is a 5- or 6-membered aromatic heterocyclic group linked via carbon or nitrogen with 1, 2 or 3 heteroatoms or R.sup.9 is --C.sub.1-5alkylR.sup.32, --C.sub.1-5alkylR.sup.96, C.sub.1-5alkyl optionally substituted by halo, --C.sub.1-5alkyl-OR.sup.20, --C.sub.1-5alkyl-NHR.sup.20, --C.sub.1-5alkyl-N(C.sub.1-3alkyl)-R.sup.20, --C.sub.1-5alkyl-NH--C.sub.1-5alkyl-OH, --C.sub.1-5alkyl-N(C.sub.1-3alkyl)-C.sub.1-5alkyl-OH and --C.sub.1-5alkyl-NR.sup.95--C.sub.1-5alkyl-OH and wherein R.sup.32, R.sup.96, R.sup.20 and R.sup.95 are as defined in claim 1. 6. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.1' is hydrogen, methoxy, N--(C.sub.1-4alkyl)piperid in-4-yloxy, prop-2-yloxy or methoxyethoxy; R.sup.2' is hydrogen or methoxy; and R.sup.4' is hydrogen. 7. A method for treating colorectal or breast cancer in a warm blooded animal, such as man, in need of such treatment, which comprises administering to said animal an effective amount of a compound of formula (IA), or a pharmaceutically acceptable salt, or an in vivo hydrolysable ester thereof as defined in claim 1. 8. A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier. 9. A process for the preparation of a compound according to claim 1 comprising the step of: a) when X is NH, reacting a compound of formula (VII) ##STR00034## where R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are R.sup.1', R.sup.2', R.sup.3', and R.sup.4' as defined in claim 7 and R.sup.85 is a group NR.sup.86R.sup.87 where R.sup.86 and R.sup.87 are independently selected from C.sub.1-4alkyl, with a compound of formula (VIII) H.sub.2N--R.sup.5' (VIII) where R.sup.5' is a group R.sup.5a as defined in claim 7; or b) when X is as defined in claim 1, reacting a compound of formula (X) ##STR00035## where R.sup.1', R.sup.2'', R.sup.3'', and R.sup.4' are equivalent to a group R.sup.1', R.sup.2', R.sup.3' and R.sup.4' as defined in claim 7, and R.sup.85 is a leaving group, with a compound of formula (XI) H--X--R.sup.5 (XI) and R.sup.5 is R.sup.5a as defined in claim 1. 10. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.60 and R.sup.62 are both hydrogen. 11. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.63 is --(CH.sub.2).sub.q'R.sup.70 and J is phenyl optionally substituted by 1 or 2 halo. 12. A compound according to claim 3, or a salt, ester or amide thereof, wherein p is 1. 13. A compound according to claim 11, or a salt, ester or amide thereof, wherein p is 1. 14. A compound according to claim 2, or a salt, ester or amide thereof, wherein X.sup.1 is --O-- or --N(C.sub.1-3alkyl)--. 15. A compound according to claim 5, or a salt, ester or amide thereof, wherein X.sup.1 is --O-- or --N(C.sub.1-3alkyl)--. 16. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sup.1' is --X.sup.1R.sup.9 where X.sup.1 is --O--, --NH-- or --NMe-- and R.sup.9 is selected from a group 1), 3), 5), 9) or 20) as defined in claim 1. 17. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.1' is --X.sup.1R.sup.9 where X.sup.1 is --O-- or --NH-- and R.sup.9 is hydrogen, C.sub.1-5alkyl, C.sub.3-6cycloalkyl, --C.sub.1-5alkyl-O--C.sub.1-3alkyl or a 5- to 6-membered saturated heterocyclic group linked via carbon or nitrogen with 1 or 2 heteroatoms selected independently from O, S or N which heterocyclic groups is optionally substituted by C.sub.1-4alkyl or a 5- or 6-membered aromatic heterocyclic group linked via carbon or nitrogen with 1, 2 or 3 heteroatoms. 18. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.1' is hydrogen, methoxy, N--(C.sub.1-4alkyl)piperidin-4-yloxy, prop-2-yloxy or methoxyethoxy. 19. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.1' is hydrogen. 20. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sup.2' is hydrogen, halo, --X.sup.1R.sup.9 where X.sup.1 is --O-- and R.sup.9 is a group 1) as defined in claim 1. 21. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.2' is hydrogen or methoxy. 22. A compound according to claim 1, or a salt, ester or amide thereof, wherein R.sup.3' is --X.sup.1R.sup.9 where X.sup.1 is --O-- and R.sup.9 is selected from a group 3), 4), 6), 18), 19) or 22) as defined in claim 1. 23. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.3' is --X.sup.1R.sup.9 where X.sup.1 is --O-- and R.sup.9 is --C.sub.1-5alkylR.sup.32, --C.sub.1-5alkylR.sup.96, C.sub.1-5alkyl optionally substituted by halo, --C.sub.1-5alkyl-OR.sup.20, --C.sub.1-5alkyl-NHR.sup.20, --C.sub.1-5alkyl-N(C.sub.1-3alkyl)-R.sup.20, --C.sub.1-5alkyl-NH--C.sub.1-5alkyl-OH, --C.sub.1-5alkyl-N(C.sub.1-3alkyl)-C.sub.1-5alkyl-OH and --C.sub.1-5alkyl-NR.sup.95--C.sup.1-5alkyl-OH. 24. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.3' is --X.sup.1R.sup.9 where X.sup.1 is --O-- and R.sup.9 is --C.sub.1-5alkylR.sup.32 where R.sup.32 is pyrrolidinyl, piperidinyl or piperazinyl each being optionally substituted by hydroxy, hydroxymethyl, 2-hydroxyethyl, methyl or 2-(tert-butoxy)ethyl; --C.sub.1-5alkyl-NHR.sup.20; --C.sub.1-5alkyl-NH--C.sub.1-5alkyl-OH; --C.sub.1-5alkyl-N(C.sub.1-3alkyl)-C.sub.1-5alkyl-OH and --C.sub.1-5alkyl-NR.sup.95--C.sub.1-5alkyl-OH. 25. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.3' is 3-morpholinopropoxy, 3-chloropropoxy, 3-[N-ethyl-N-(2-hydroxyethyl)amino]propoxy, 3-(2-hydroxymethylpyrrolidin-1-yl)propoxy, 3-(piperidin-1-yl)propoxy, 3-(pyrrolidin-1-yl)propoxy, 3-(N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2-hydroxy-1,1-dimethylethyl)amino}propoxy, 3-[N-methyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(1-hydroxymethyl-2-methylpropyl)amino]propoxy, 3-(4-methylpiperazin-1-yl)propoxy, 3-[N-(2-hydroxy-1-methylethyl)amino]propoxy, 3-[N-(4-hydroxybutyl)amino]propoxy, 3-(4-hydroxypiperidin-1-yl)propoxy, 3-[2-(2-hydroxyethyl)piperidin-1-yl]propoxy, 3-[4-(2-hydroxyethyl)piperazin-1-yl]propoxy, 3-[4-(2-hydroxyethyl)piperidin-1-yl]propoxy, 3-(3-hydroxypiperidin-1-yl)propoxy, 3-[N-2-(hydroxybutyl)amino]propoxy, 3-(4-hydroxymethylpiperidin-1-yl)propoxy, 3-[N-(3-hydroxy-2,2-dimethylpropyl)amino]propoxy, 3-[N-(1-hydroxymethylcyclopent-1-yl)amino]propoxy, 3-[N-(2-hydroxypropyl)amino]propoxy, 3-(3-hydroxypyrrolidin-1-yl)propoxy, 3-[N-(2-fluoroethyl)-N-(2-hydroxyethyl)amino]propoxy, 2-[1-(2-hydroxyethyl)piperidin-4-yl]ethoxy, 3-[N-(2-hydroxyethyl)-N-propylamino]propoxy, 3-[N-(2-hydroxyethyl)-N-(prop-2-yl)amino]propoxy, 3-[N-(2-hydroxyethyl)-N-isobutylamino]propoxy, 3-[N-(2-hydroxyethyl)-N-neopentylamino]propoxy, 3-[N-allyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2-hydroxyethyl)-N-(prop-2-yn-1-yl)amino]propoxy, 3-[N-cyclopropyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-cyclopropylmethyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-cyclobutyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-cyclopentyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2,2-dimethoxyethyl)-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2,2-difluoroethyl)-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2-hydroxyethyl)-N-(3,3,3-trifluoropropyl)amino]propoxy, 3-[N-cyclobutylmethyl-N-(2-hydroxyethyl)amino]propoxy, 3-[N-(2-hydroxyethyl)-N-(2-methoxyethyl)amino]propoxy, 3-[N-(1,3-dioxolan-2-ylmethyl)-N-(2-hydroxyethyl)amino]propoxy, 4-chlorobutoxy, 4-[(2-hydroxymethyl)pyrrolidin-1-yl]butoxy, 4-[N-(2-hydroxyethyl)-N-isobutylamino]butoxy, 1-(2-tert-butoxyethyl)pyrrolidin-2-ylmethoxy, 1-(2-hydroxyethyl)pyrrolidin-2-ylmethoxy, 3-[N-2-(hydroxyethyl)-N-(iso-butyl)amino]propoxy, 3-[N-2-(hydroxyethyl)-N-(neopentyl)amino]propoxy, 3-[N-2-(hydroxyethyl)-N-(tert-butyl)amino]propoxy, methoxy and methoxyethoxy. 26. A compound according to claim 2, or a salt, ester or amide thereof, wherein R.sup.4' is hydrogen. 27. A compound according to claim 23, or a salt, ester or amide thereof, wherein R.sup.1' is hydrogen, R.sup.2' is hydrogen or methoxy and R.sup.4' is hydrogen. 28. A compound according to claim 25, or a salt, ester or amide thereof, wherein R.sup.1' is hydrogen, R.sup.2' is hydrogen or methoxy and R.sup.4' is hydrogen. 29. A compound according to claim 2, or a salt, ester or amide thereof, wherein X is NR.sup.6 or O. 30. A compound according to claim 2, or a salt, ester or amide thereof, wherein X is NH. 31. A compound according to claim 27, or a salt, ester or amide thereof, wherein X is NH. 32. A compound according to claim 28, or a salt, ester or amide thereof, wherein X is NH. 33. A compound according to claim 1 selected from: 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyr- azol-5-yl)-N-phenylacetamide; N-(3-fluorophenyl)-2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin- -4-yl]amino}-1H-pyrazol-5-yl)acetamide; 2-(3-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-y- l)-N-(3-fluorophenyl)acetamide; 2-(3-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-y- l)-N-(3,5-difluorophenyl)acetamide; 2-(3-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-y- l)-N-(2,3-difluorophenyl)acetamide; N-(3-chlorophenyl)-2-(3-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]am- ino}-1H-pyrazol-5-yl)acetamide; 2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-(3-{[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin- -4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-(3-{[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoli- n-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxy-1,1-dimethylethyl)amino]propox- y}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(methyl)amino]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-(3-{[7-(3-{[1-(hydroxymethyl)-2-methylpropyl]amino}p- ropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-[3-({6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]- quinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxy-1-methylethyl)amino]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(4-hydroxybutyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-[3-({7-[3-(4-hydroxypiperidin-1-yl)propoxy]-6-methox- yquinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[2-(2-hydroxyethyl)piperidin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperidin-1-yl]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-[3-({7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-methox- yquinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxybutyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(3-hydroxy-2,2-dimethylpropyl)amino]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-(3-{[7-(3-{[1-(hydroxymethyl)cyclopentyl]amino}propo- xy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-(3-{[7-(3-{[(2S)-2-hydroxypropyl]amino}propoxy)-6-me- thoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-(3-{[7-(3-{[(2R)-2-hydroxypropyl]amino}propoxy)-6-me- thoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(3S)-3-hydroxypyrrolidin-1-yl]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(3R)-3-hydroxypyrrolidin-1-yl]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[(2-fluoroethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyquina- zolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{2-[1-(2-hydroxyethyl)piperidin-4-yl]ethoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy}-6-- methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)amino]propoxy}-6-methoxy- quinzolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[allyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[cyclopropyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[cyclobutyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[(2,2-dimethoxyethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxy- quinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-{3-[(7-{3-[(2,2-difluoroethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(3,3,3-trifluoropropyl)am- ino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[(cyclobutylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyqu- inazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[(1,3-dioxolan-2-ylmethyl)(2-hydroxyethyl)amino]propoxy}-6-me- thoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; 2-(3-{[7-(4-chlorobutoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl- )-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{4-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]but- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-{3-[(7-{4-[(2-hydroxyethyl)(isobutyl)amino]butoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{[(2R)-1-(2-tert-butoxyethyl)pyrrolidin-2-yl]methoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide; N-(3-fluorophenyl)-2-{3-[(7-{[(2R)-1-(2-hydroxyethyl)pyrrolidin-2-yl]meth- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-(3-{[6-methoxy-7-(3-pyrroldin-1-ylpropoxy)quinaz- olin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)amino]propoxy}-6-meth- oxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxy-1,1-dimethylethyl)amino]pr- opoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-[3-({6-methoxy-7-[3-(4-methylpiperazin-1-yl)prop- oxy]quinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[2-(2-hydroxyethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-[3-({7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-me- thoxyquinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxybutyl)amino]propoxy}-6-meth- oxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(3-hydroxy-2,2-dimethylpropyl)amino]p- ropoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-(3-{[7-(3-{[(2S)-2-hydroxypropyl]amino}propoxy)-- 6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3,5-difluorophenyl)-2-(3-{[7-(3-{[(2R)-2-hydroxypropyl]amino}propoxy)-- 6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(3S)-3-hydroxypyrrolidin-1-yl]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(3R)-3-hydroxypyrrolidin-1-yl]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propo- xy}6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[allyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-5-yl}-N-(3,5-difluorophenyl)acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-difluorophenyl)-2-{3-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)a- mino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[cyclobutyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(3,5-difluorophenyl)acetamide; 2-{3-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3,5-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)a- mino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy- }-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[cyclobutyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; 2-{3-[(7-{3-[cyclopentyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazoli- n-4-yl)amino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[(cyclopropylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyq- uinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; 2-{3-[(7-{3-[(cyclobutylmethyl)(2-hydroxyethyl)amino]propoxy}-6-methoxyqu- inazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2,2-dimethoxyethyl)(2-hydroxyethyl)a- mino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-[3-({7-[3-(4-hydroxypiperidin-1-yl)propoxy]-6-me- thoxyquinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[4-(2-hydroxyethyl)piperazin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(2-methoxyethyl)amino- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[allyl(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl- )amino]-1H-pyrazol-5-yl}-N-(2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(1,3-dioxolan-2-ylmethyl )(2-hydroxyethyl)amino]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazo- l-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxy-1,1-dimethylethyl)amino]pr- opoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{[(2R)-1-(2-hydroxyethyl)pyrrolidin-2-yl]- methoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chlorophenyl)-2-{3-[(7-{3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pro- poxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chlorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrroldin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chlorophenyl)-2-[3-({7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-methox- yquinazolin-4-yl}amino)-1H-pyrazol-5-yl]acetamide; N-(3-chlorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-6-met- hoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(3-methoxyphenyl)acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-phenylacetamide; N-(4-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-dichlorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(5-chloro-2-methoxyphenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl- ]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-[3-(trifluoromethyl)phenyl]acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(3-hydroxyphenyl)acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(3-nitrophenyl)acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-1H-indazol-5-ylacetamide; N-(4-bromo-2-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]p- ropoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chlorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-- 6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3,5-dimethoxyphenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]prop- oxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6-methoxyquinazolin- -4-yl)amino]-1H-pyrazol-5-yl}-N-(5-methylpyridin-2-yl)acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chloro-2-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]- propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,5-difluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-[2-fluoro-5-(trifluoromethyl)phenyl]-2-{3-[(7-{3-[4-(hydroxymethyl)pipe- ridin-1-yl]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetam- ide; N-(3,4-difluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]p- ropoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,4-difluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propo- xy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-chloro-4-fluorophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]- propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-[2-(difluoromethoxy)phenyl]-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-y- l]propoxy}-6-methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-cyanophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-bromophenyl)-2-{3-[(7-{3-[4-(hydroxymethyl)piperidin-1-yl]propoxy}-6- -methoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}qu- inazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isopropyl)amino]prop- oxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl- ]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(propyl)amino]propoxy- }quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(prop-2-yn-1-yl)amino- ]propoxy}quinzolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propo- xy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(2,3-difluorophenyl)-2-{3-[(7-{3-[(2,2-dimethylpropyl)(2-hydroxyethyl)a- mino]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; N-(3-fluorophenyl)-2-[3-({5-{[1-(2-hydroxyethyl)piperidin-4-yl]oxy}-7-[3-- (4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl}amino)-1H-pyrazol-5-yl]ace- tamide; N-(3-fluorophenyl)-2-[5-({7-methoxy-5-[(1-methylpiperidin-4-yl)oxy- ]quinazolin-4-yl}amino)-1H-pyrazol-3-yl]acetamide; N-(2,3-difluorophenyl)-2-{3-[(5,7-dimethoxyquinazolin-4-yl)amino]-1H-pyra- zol-5-yl}acetamide; 2-(3-{[5,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-- (2,3-difluorophenyl)acetamide; N-(2,3-difluorophenyl)-2-(3-{[5-isopropoxy-7-(2-methoxyethoxy)quinazolin-- 4-yl]amino}-1H-pyrazol-5-yl)acetamide; N-(3-fluorophenyl )-2-(3-{[5-isopropoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino}-1H-pyrazo- l-5-yl)acetamide; N-(3-fluorophenyl)-2-{3-[(5-{[1-(2-hydroxyethyl)piperidin-4-yl]oxy}-7-met- hoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide; 2-{3-[(5,7-dimethoxyquinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluoroph- enyl)acetamide; 2-(3-{[5,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-- (3-fluorophenyl)acetamide; N-(3-fluorophenyl)-3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propoxy}-6-m- ethoxyquinazolin-4-yl)amino]-1H-pyrazole-5-carboxamide; and N-(2,3-difluorophenyl)-3-[(7-{3-[(2-hydroxyethyl)(isobutyl)amino]propoxy}- -6-methoxyquinazolin-4-yl)amino]-1H-pyrazole-5-carboxamide; or a pharmaceutically acceptable salt thereof. 